A common cholesterol drug may weaken ovarian cancer’s hidden shield

Duke University School of Medicine researcher Yasaman Setayeshpour, Ph.D., studies how a common class of cholesterol drugs, called fibrates, can strip away a key defense…

Continue Reading


News Source: medicalxpress.com

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *